Atria Investments Inc Decreases Position in CME Group Inc. (NASDAQ:CME)

Atria Investments Inc cut its stake in CME Group Inc. (NASDAQ:CME) by 13.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 29,050 shares of the financial services provider’s stock after selling 4,370 shares during the quarter. Atria Investments Inc’s holdings in CME Group were worth $6,410,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Capital International Investors grew its holdings in CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after buying an additional 3,069,806 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in shares of CME Group by 11.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after purchasing an additional 537,758 shares during the period. GUARDCAP ASSET MANAGEMENT Ltd boosted its position in shares of CME Group by 1.1% during the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock valued at $863,112,000 after buying an additional 43,293 shares during the period. Raymond James & Associates grew its position in CME Group by 3.2% in the 2nd quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock valued at $595,530,000 after acquiring an additional 94,302 shares during the last quarter. Finally, Legal & General Group Plc grew its holdings in shares of CME Group by 6.6% in the second quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock worth $557,371,000 after purchasing an additional 176,004 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CME has been the topic of several research reports. Bank of America raised their price objective on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. TD Cowen started coverage on shares of CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target on the stock. Keefe, Bruyette & Woods upped their target price on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Morgan Stanley upped their price target on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Finally, JPMorgan Chase & Co. increased their price objective on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $224.47.

CME Group Stock Up 0.1 %

Shares of CME opened at $225.93 on Tuesday. The firm has a market cap of $81.36 billion, a P/E ratio of 23.76, a PEG ratio of 5.68 and a beta of 0.55. The stock’s 50 day moving average is $221.72 and its two-hundred day moving average is $209.84. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. CME Group’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period in the previous year, the business earned $2.25 EPS. Analysts predict that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.04%. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Insider Buying and Selling at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock worth $3,441,063 in the last three months. 0.30% of the stock is owned by corporate insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.